Wright Investors Service Inc. acquired a new stake in shares of Genpact Limited (NYSE:G - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 10,391 shares of the business services provider's stock, valued at approximately $457,000.
A number of other hedge funds and other institutional investors have also bought and sold shares of G. Wealth Enhancement Advisory Services LLC grew its stake in shares of Genpact by 2.5% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 9,890 shares of the business services provider's stock worth $454,000 after buying an additional 240 shares during the last quarter. Fifth Third Bancorp lifted its stake in Genpact by 9.5% in the first quarter. Fifth Third Bancorp now owns 3,461 shares of the business services provider's stock worth $174,000 after purchasing an additional 299 shares during the last quarter. Petrus Trust Company LTA raised its stake in shares of Genpact by 2.2% during the first quarter. Petrus Trust Company LTA now owns 14,390 shares of the business services provider's stock valued at $725,000 after acquiring an additional 305 shares in the last quarter. KBC Group NV increased its holdings in Genpact by 4.7% during the first quarter. KBC Group NV now owns 7,266 shares of the business services provider's stock valued at $366,000 after buying an additional 324 shares during the period. Finally, Callan Capital LLC grew its holdings in Genpact by 2.9% in the first quarter. Callan Capital LLC now owns 12,312 shares of the business services provider's stock worth $620,000 after purchasing an additional 351 shares during the last quarter. Institutional investors own 96.03% of the company's stock.
Genpact Price Performance
Shares of NYSE:G traded down $0.17 on Friday, hitting $41.13. The company's stock had a trading volume of 5,115,371 shares, compared to its average volume of 1,768,660. The company has a 50-day simple moving average of $44.05 and a 200 day simple moving average of $45.45. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.53 and a quick ratio of 1.53. Genpact Limited has a 1 year low of $37.82 and a 1 year high of $56.76. The company has a market capitalization of $7.17 billion, a PE ratio of 13.66, a PEG ratio of 1.41 and a beta of 0.92.
Genpact (NYSE:G - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The business services provider reported $0.88 earnings per share for the quarter, beating the consensus estimate of $0.85 by $0.03. Genpact had a return on equity of 22.15% and a net margin of 10.92%.The company had revenue of $1.25 billion for the quarter, compared to analyst estimates of $1.23 billion. During the same period in the previous year, the company posted $0.79 earnings per share. The firm's revenue was up 6.6% on a year-over-year basis. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. Sell-side analysts forecast that Genpact Limited will post 3.21 EPS for the current fiscal year.
Genpact Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Thursday, September 11th will be issued a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 1.7%. The ex-dividend date is Thursday, September 11th. Genpact's dividend payout ratio (DPR) is presently 22.59%.
Wall Street Analyst Weigh In
G has been the subject of a number of research reports. Deutsche Bank Aktiengesellschaft assumed coverage on shares of Genpact in a research report on Thursday, July 17th. They set a "hold" rating and a $47.00 target price for the company. JPMorgan Chase & Co. dropped their target price on shares of Genpact from $55.00 to $50.00 and set a "neutral" rating on the stock in a research report on Wednesday, August 20th. Wall Street Zen cut shares of Genpact from a "buy" rating to a "hold" rating in a research note on Friday, September 5th. Mizuho lifted their target price on shares of Genpact from $48.00 to $51.00 and gave the stock a "neutral" rating in a research report on Tuesday, July 1st. Finally, Needham & Company LLC boosted their price objective on shares of Genpact from $50.00 to $53.00 and gave the company a "buy" rating in a research report on Friday, August 8th. Three research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, Genpact has a consensus rating of "Hold" and a consensus target price of $52.29.
Read Our Latest Report on G
Insiders Place Their Bets
In other news, SVP Piyush Mehta sold 76,902 shares of Genpact stock in a transaction on Friday, September 12th. The stock was sold at an average price of $42.58, for a total value of $3,274,487.16. Following the transaction, the senior vice president directly owned 134,880 shares in the company, valued at approximately $5,743,190.40. This trade represents a 36.31% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Balkrishan Kalra sold 55,000 shares of Genpact stock in a transaction dated Thursday, September 11th. The stock was sold at an average price of $43.36, for a total value of $2,384,800.00. Following the sale, the chief executive officer directly owned 295,246 shares of the company's stock, valued at approximately $12,801,866.56. This represents a 15.70% decrease in their position. The disclosure for this sale can be found here. Company insiders own 2.80% of the company's stock.
About Genpact
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Further Reading

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report